{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:12:28Z","timestamp":1777929148444,"version":"3.51.4"},"reference-count":17,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Orbital myositis (OM) is an uncommon ocular manifestation of systemic lupus erythematosus (SLE) and is typically characterized by acute painful proptosis and diplopia. Only isolated painful cases have been documented, and these usually occur without systemic activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case<\/jats:title>\n                    <jats:p>\n                      A 44-year-old woman with a six-year history of SLE developed\n                      <jats:italic toggle=\"yes\">painless bilateral proptosis<\/jats:italic>\n                      and mild abduction restriction during a severe multisystem flare involving the kidneys, lungs, and gallbladder. Laboratory studies revealed high anti-dsDNA titres, hypocomplementemia, and elevated inflammatory markers. Orbital computed tomography demonstrated isolated enlargement of both lateral rectus muscles without evidence of infection, sinus disease, or thyroid orbitopathy. She received intravenous methylprednisolone 1000\u00a0mg daily for 3 days, followed by an oral prednisone taper (1\u00a0mg\/kg\/day) and intravenous cyclophosphamide 1000\u00a0mg every 4 weeks for six pulses. Both ocular and systemic manifestations resolved within 24 hours of initiating pulse therapy. During admission, she developed acalculous cholecystitis, attributed to active lupus vasculitis after multidisciplinary assessment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This represents the first reported case of painless orbital myositis associated with systemic lupus erythematosus during a multi-systemic flare. Rapid response to corticosteroid and cyclophosphamide therapy underscores the inflammatory, reversible nature of this manifestation. Recognition of OM as a potential lupus complication is critical for prompt diagnosis, exclusion of infectious causes, and early initiation of aggressive immunosuppression to preserve vision and prevent systemic morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033261415992","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:58:29Z","timestamp":1767776309000},"page":"316-319","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Painless bilateral orbital myositis during a multisystem flare of systemic lupus erythematosus: Case report and focused literature review"],"prefix":"10.1177","volume":"35","author":[{"given":"Ludovica","family":"Lauretta","sequence":"first","affiliation":[{"name":"Universit\u00e9 Libre de Bruxelles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-1810","authenticated-orcid":false,"given":"Muhammad","family":"Soyfoo","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Libre de Bruxelles"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"4","key":"e_1_3_6_2_2","first-page":"514","article-title":"Global prevalence and incidence of systemic lupus erythematosus: a comprehensive meta-analysis","volume":"82","author":"Tian J","year":"2023","unstructured":"Tian J, Zhang Y, Ma L, et al. Global prevalence and incidence of systemic lupus erythematosus: a comprehensive meta-analysis. Ann Rheum Dis 2023; 82(4): 514\u2013522.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"e_1_3_6_3_2","first-page":"487","article-title":"Ocular manifestations of systemic lupus erythematosus","volume":"33","author":"Jabs DA","year":"2022","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 2022; 33(6): 487\u2013494.","journal-title":"Curr Opin Ophthalmol"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1994.tb02807.x"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2020.19217"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05114-3"},{"issue":"12","key":"e_1_3_6_7_2","first-page":"003038","article-title":"Refractory orbital myositis in systemic lupus erythematosus: a role for rituximab","volume":"8","author":"Rodrigues Morais J","year":"2021","unstructured":"Rodrigues Morais J, Rodrigues Santos R, Pires Costa P, et al. Refractory orbital myositis in systemic lupus erythematosus: a role for rituximab. Eur J Case Rep Intern Med 2021; 8(12): 003038.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"2","key":"e_1_3_6_8_2","first-page":"102","article-title":"Orbital myositis associated with discoid lupus erythematosus","volume":"206","author":"Kono K","year":"1993","unstructured":"Kono K, Oshima Y, Mimura Y, et al. Orbital myositis associated with discoid lupus erythematosus. Ophthalmologica 1993; 206(2): 102\u2013106.","journal-title":"Ophthalmologica"},{"issue":"1","key":"e_1_3_6_9_2","first-page":"71","article-title":"Orbital myositis associated with discoid lupus erythematosus","volume":"22","author":"Gupta N","year":"2003","unstructured":"Gupta N, Aggarwal A, Jain R, et al. Orbital myositis associated with discoid lupus erythematosus. Orbit 2003; 22(1): 71\u201375.","journal-title":"Orbit"},{"issue":"3","key":"e_1_3_6_10_2","first-page":"837","article-title":"Lupus erythematosus presenting with orbital myositis: a rare manifestation","volume":"35","author":"Arrico L","year":"2016","unstructured":"Arrico L, Abbouda A, Malagola R, et al. Lupus erythematosus presenting with orbital myositis: a rare manifestation. Clin Rheumatol 2016; 35(3): 837\u2013840.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"e_1_3_6_11_2","first-page":"193","article-title":"Imaging of orbital inflammatory disease: what the clinician needs to know","volume":"9","author":"Ferreira TA","year":"2018","unstructured":"Ferreira TA, van der Meyden A, Mourits MP, et al. Imaging of orbital inflammatory disease: what the clinician needs to know. Insights Imaging 2018; 9(2): 193\u2013208.","journal-title":"Insights Imaging"},{"issue":"14","key":"e_1_3_6_12_2","first-page":"1572","article-title":"Acalculous cholecystitis as a manifestation of systemic lupus erythematosus: case report and literature review","volume":"21","author":"Hsu CC","year":"2012","unstructured":"Hsu CC, Chen YJ, Chen WS, et al. Acalculous cholecystitis as a manifestation of systemic lupus erythematosus: case report and literature review. Lupus 2012; 21(14): 1572\u20131576.","journal-title":"Lupus"},{"issue":"3","key":"e_1_3_6_13_2","first-page":"357","article-title":"Lupus cholecystitis: an uncommon cause of acute cholecystitis","volume":"28","author":"Woo KS","year":"2009","unstructured":"Woo KS, Kim Y, Choi YJ, et al. Lupus cholecystitis: an uncommon cause of acute cholecystitis. Clin Rheumatol 2009; 28(3): 357\u2013360.","journal-title":"Clin Rheumatol"},{"key":"e_1_3_6_14_2","first-page":"1442873","article-title":"Cytokine networks in orbital inflammation: insights from thyroid eye disease and idiopathic orbital inflammation","volume":"15","author":"Ang T","year":"2024","unstructured":"Ang T, Wong KH, Tan R, et al. Cytokine networks in orbital inflammation: insights from thyroid eye disease and idiopathic orbital inflammation. Front Immunol 2024; 15: 1442873.","journal-title":"Front Immunol"},{"issue":"5","key":"e_1_3_6_15_2","first-page":"103562","article-title":"Interleukin-driven pathogenesis in autoimmune orbital diseases: implications for targeted therapy","volume":"23","author":"Aoun T","year":"2024","unstructured":"Aoun T, El Khatib M, Chouman M, et al. Interleukin-driven pathogenesis in autoimmune orbital diseases: implications for targeted therapy. Autoimmun Rev 2024; 23(5): 103562.","journal-title":"Autoimmun Rev"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.1.109"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8517-0"},{"issue":"1","key":"e_1_3_6_18_2","first-page":"e21","article-title":"Management of severe lupus flare: role of high-dose corticosteroids and cyclophosphamide","volume":"21","author":"Hewins P","year":"2021","unstructured":"Hewins P, Hart A, Nandha S, et al. Management of severe lupus flare: role of high-dose corticosteroids and cyclophosphamide. Clin Med (Lond) 2021; 21(1): e21\u2013e27.","journal-title":"Clin Med (Lond)"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261415992","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033261415992","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261415992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:29:40Z","timestamp":1777678180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033261415992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/09612033261415992"],"URL":"https:\/\/doi.org\/10.1177\/09612033261415992","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}